Immunocore Holdings plc (IMCR)
NASDAQ·Healthcare·Biotechnology
$30.40
-2.78%
Mkt Cap $1.69B
Analyst Ratings
No recent rating data.
Price Target (16 analysts)
$39.00
Range $35.00 – $43.00
Implied Upside
+28.3%
Consensus $39.00 vs current $30.40
NASDAQ·Healthcare·Biotechnology
$30.40
-2.78%
Mkt Cap $1.69B
No recent rating data.
Price Target (16 analysts)
$39.00
Range $35.00 – $43.00
+28.3%
Consensus $39.00 vs current $30.40